Curcumin exerts therapeutic effects in GBM via multiple pathways, including the suppression of AKT/mTOR and activation of ERK1/2 pathways in human malignant glioma U87-MG and U373-MG with PTEN mutations15. This evidence concerns the gene MTOR and glioblastoma.